EnzymeBioSystems Appoints New Chief Executive Officer - Tucson News Now

EnzymeBioSystems Appoints New Chief Executive Officer

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE EnzymeBioSystems

CHAGRIN FALLS, Ohio, May 23, 2014 /PRNewswire/ -- EnzymeBioSystems (OTCBB: ENZB) (OTCQB: ENZB), announces the appointment of Gary Rojewski as its new CEO, effective June 2, 2014. Mr. Rojewski will be responsible for leading and managing EnzymeBioSystems' business operations, including regulatory affairs with government agencies.

Mr. Rojewski has 29-years experience in the pharmaceutical industry. During that time he has worked for Procter and Gamble Pharmaceuticals (PG), Warner Chilcott Pharmaceuticals, Inc. (WCRX) and most recently, Actavis (ACT). Throughout his pharmaceutical career, he has been responsible for commercializing pharmaceutical products.

"We are very happy that Gary has joined EnzymeBioSystems to lead our operations. His expertise in the pharmaceutical industry is a great fit for our business strategy," said Anushavan Yeranosyan, Chief Accounting Officer.

Commenting on his new role, Mr. Rojewski said: "I am pleased to be joining EnzymeBioSystems at such an exciting time for the Company. My first goal is to help the Company position itself with the products under development. I plan to deliver and utilize my resources to move the Company forward."

About EnzymeBioSystems
EnzymeBioSystems manufactures specialty enzymes and enzyme related products.  We plan to use enzyme technologies to develop commercial solutions for a broad range of applications within the pharmaceutical industry.  http://enzymebiosystems.com/

Included in this release are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Although the company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations reflected in such forward-looking statements will prove to have been correct.  The company's actual results could differ materially from those anticipated in the forward-looking statements.

Contact Info:

EnzymeBioSystems
+44(0)-708-0012
info@enzymebiosystems.com 
http://enzymebiosystems.com/

©2012 PR Newswire. All Rights Reserved.

  • Latest Health NewsThe Latest from HealthDayMore>>

  • The 'Hobby Lobby ruling' and what it means for U.S. health care

    The 'Hobby Lobby ruling' and what it means for U.S. health care

    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
    The U.S. Supreme Court's ruling on contraception coverage -- as mandated under the Affordable Care Act -- could lead to a legal quagmire that might allow companies to deny insurance coverage for any medical practice that violates their religious principles.
  • Diet changes can alter gut bacteria

    Diet changes can alter gut bacteria

    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
    Dietary changes can dramatically alter the balance of bacteria in the gut on a daily basis, according to a new study.
  • Lift U.S. ban on blood donations by gay men

    Lift U.S. ban on blood donations by gay men

    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical...
    The United States should repeal a 30-year policy that bans blood donations from gay and bisexual men, according to a team of medical and legal experts writing this week in the Journal of the American Medical Association.
Powered by WorldNow